ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,839,723 | +107.5% | 142,900 | +175.3% | 0.01% | +100.0% |
| Q2 2023 | $1,850,754 | +127.7% | 51,900 | +62.2% | 0.01% | +150.0% |
| Q1 2023 | $812,800 | -35.8% | 32,000 | +57.6% | 0.00% | -33.3% |
| Q3 2021 | $1,267,000 | -71.6% | 20,300 | -62.3% | 0.00% | -75.0% |
| Q2 2021 | $4,456,000 | -32.7% | 53,800 | -46.1% | 0.01% | -33.3% |
| Q1 2021 | $6,618,000 | +59.1% | 99,800 | +84.1% | 0.02% | +63.6% |
| Q4 2020 | $4,159,000 | -50.5% | 54,200 | -72.2% | 0.01% | -54.2% |
| Q3 2020 | $8,410,000 | -70.6% | 195,300 | -70.5% | 0.02% | -71.4% |
| Q2 2020 | $28,639,000 | +59.1% | 663,100 | +6.0% | 0.08% | +21.7% |
| Q1 2020 | $17,996,000 | +84.0% | 625,500 | +305.6% | 0.07% | +200.0% |
| Q4 2019 | $9,781,000 | +233.7% | 154,200 | +48.3% | 0.02% | +228.6% |
| Q3 2019 | $2,931,000 | -54.4% | 104,000 | -57.1% | 0.01% | -56.2% |
| Q2 2019 | $6,424,000 | +368.6% | 242,400 | +224.5% | 0.02% | +433.3% |
| Q1 2019 | $1,371,000 | +258.0% | 74,700 | +273.5% | 0.00% | +200.0% |
| Q3 2018 | $383,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |